NY S 6925
in committeeRelates to capping cost sharing for antiviral COVID-19 therapeutics
New York · 2025-2026 Regular Session · upper
Description
Requires insurance companies, medical expense indemnity corporations, hospital service corporations, health service corporations and medical assistance programs to provide coverage for prescribed antiviral therapeutics approved by the food and drug administration for the treatment of COVID-19 at no cost to the patient.
- Introduced
- —
- Status date
- —
- Latest action
- 2025-03-27 — REFERRED TO INSURANCE
- Bill type
- bill
- Last updated
- —
Sponsors
- Brad Hoylman-Sigalprimary
Committees
Not provided by source.
Action timeline
2025-03-27
REFERRED TO INSURANCE
referral-committee
Versions
- S6925Compare
Documents
- application/pdf(no extracted text yet)
- text/html(no extracted text yet)
Votes
Not provided by source.
Related bills
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:28:30.722574Z
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=NY&identifier=S 6925. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
- Some documents have no extracted text yet, so version comparison may be limited.
See the methodology page for data sources and limitations.